Clinical Trial Update: The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on intravitreal topotecan for proliferative vitreoretinopathy; the study assesses safety and potential efficacy, with recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Vitreoretinopathy
• Rhegmatogenous Retinal Detachment

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Proliferative Vitreoretinopathy, Proliferative Vitreo-Retinopathy | Phase 1 | Status: NOT_YET_RECRUITING